LJPC - La Jolla Pharmaceutical Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5275.63M
Enterprise Value 3335.12M
Trailing P/E N/A
Forward P/E 1-3.39
PEG Ratio (5 yr expected) 1-0.18
Price/Sales (ttm)15.53
Price/Book (mrq)N/A
Enterprise Value/Revenue 318.88
Enterprise Value/EBITDA 6-2.39

Trading Information

Stock Price History

Beta (3Y Monthly) 2.93
52-Week Change 3-52.05%
S&P500 52-Week Change 32.63%
52 Week High 322.00
52 Week Low 35.01
50-Day Moving Average 39.73
200-Day Moving Average 38.23

Share Statistics

Avg Vol (3 month) 3391.11k
Avg Vol (10 day) 3353.81k
Shares Outstanding 527.13M
Float 15.22M
% Held by Insiders 16.08%
% Held by Institutions 1104.64%
Shares Short (Aug 15, 2019) 45.65M
Short Ratio (Aug 15, 2019) 416.49
Short % of Float (Aug 15, 2019) 434.05%
Short % of Shares Outstanding (Aug 15, 2019) 420.82%
Shares Short (prior month Jul 15, 2019) 46.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 250/1
Last Split Date 3Jan 14, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-816.09%

Management Effectiveness

Return on Assets (ttm)-40.87%
Return on Equity (ttm)-307.09%

Income Statement

Revenue (ttm)17.75M
Revenue Per Share (ttm)0.66
Quarterly Revenue Growth (yoy)258.00%
Gross Profit (ttm)-106.49M
EBITDA -140.29M
Net Income Avi to Common (ttm)-158.26M
Diluted EPS (ttm)-5.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)123.45M
Total Cash Per Share (mrq)4.55
Total Debt (mrq)154.89M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.02
Book Value Per Share (mrq)-0.61

Cash Flow Statement

Operating Cash Flow (ttm)-118.15M
Levered Free Cash Flow (ttm)-66.88M